Dow Up 0.00% Nasdaq Up 0.09%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
21.07 Down 0.77(3.53%) Nov 28, 1:00PM EST
Prev Close:21.84
Open:21.88
Bid:20.84 x 200
Ask:21.31 x 200
1y Target Est:34.38
Beta:-0.44
Earnings Date:Feb 24 - Mar 2 (Est.)
Day's Range:21.02 - 21.90
52wk Range:19.10 - 74.58
Volume:189,445
Avg Vol (3m):1,318,070
Market Cap:599.13M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRDown 3.53%599.13M
AZNUp 0.35%93.68B
MRKUp 1.09%172.19B
PFEUp 0.16%196.27B

Key Statistics

Forward P/E (1 yr):110.89
P/S (ttm):4.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.99
Quarterly EPS Est (Dec-14) :-0.02
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback